Paresh Kumar

Paresh Kumar, PharmD, JD, serves as Vice President, Biotech Private Equity at Ally Bridge Group in Boston, MA, where he joined in 2024. In this role, he leads deal sourcing, due diligence, and transaction execution, with an explicit focus on private equity investments in the biotechnology sector. His investment activities are centered on therapeutics, platform biotechnologies, and emerging life sciences companies, often holding board observer roles at innovative biotech startups.

Prior to joining Ally Bridge Group, Paresh was a senior associate at Goodwin Procter’s Life Sciences practice, where he executed complex corporate financing and strategic transactions representing both biotech and medtech companies. His earlier career included associate positions at Morrison & Foerster and McDermott Will & Emery, experience in Boston University’s technology transfer office, an internship at MPM Capital, and serving as a financial analyst at Takeda.

Paresh is academically distinguished with a B.S. and Pharm.D. from Northeastern University and a J.D. from Boston University School of Law. With expertise at the intersection of science, law, and finance, he has contributed to numerous high-profile biotech investments and is recognized for his leadership and mentorship within the industry, particularly in fostering diversity in biotech investing.